Patents by Inventor Thomas E. Wagner

Thomas E. Wagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12644890
    Abstract: Described herein are methods and compositions for isolating cancer cells using positively charged surfaces, such as beads, microparticles, and capillary tubes. The methods and compositions for isolation can be used in cancer diagnosis, treatment, and therapeutic preparation.
    Type: Grant
    Filed: May 6, 2025
    Date of Patent: June 2, 2026
    Assignee: Elios Holdings, LLC
    Inventors: Thomas E. Wagner, Amanda J. Sloan, Xianzhong Yu
  • Patent number: 12453768
    Abstract: The present disclosure provides particles for delivering a nucleic acid that encodes an immunogenic peptide in an antigen presenting cell. The disclosed particles can function as a vaccine and can be used to treat or prevent a viral or bacterial infection in a subject by expressing in vivo an immunogenic peptide, thereby stimulating the subject's immune system to attack the virus or bacteria that naturally express the immunogenic peptide.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: October 28, 2025
    Assignee: ORBIS HEALTH SOLUTIONS, LLC
    Inventor: Thomas E. Wagner
  • Publication number: 20250264386
    Abstract: Described herein are methods and compositions for isolating cancer cells using positively charged surfaces, such as beads, microparticles, and capillary tubes. The methods and compositions for isolation can be used in cancer diagnosis, treatment, and therapeutic preparation.
    Type: Application
    Filed: May 6, 2025
    Publication date: August 21, 2025
    Applicant: ORBIS HEALTH SOLUTIONS, LLC
    Inventors: Thomas E. Wagner, Amanda J. Sloan, Xianzhong Yu
  • Publication number: 20250009875
    Abstract: The present disclosure provides particles for delivering a nucleic acid that encodes an immunogenic peptide in an antigen presenting cell. The disclosed particles can function as a vaccine and can be used to treat or prevent a viral or bacterial infection in a subject by expressing in vivo an immunogenic peptide, thereby stimulating the subject's immune system to attack the virus or bacteria that naturally express the immunogenic peptide.
    Type: Application
    Filed: December 20, 2022
    Publication date: January 9, 2025
    Applicant: ORBIS HEALTH SOLUTIONS, LLC
    Inventor: Thomas E. Wagner
  • Publication number: 20240350540
    Abstract: Dendritic cells containing tumor lysate loaded particles are prepared. The dendritic cells present tumor antigens to elicit the Major Histocompatibility Complex class I pathway and can be used as a vaccine to treat cancer, including ocular melanoma.
    Type: Application
    Filed: December 22, 2023
    Publication date: October 24, 2024
    Applicant: Orbis Health Solutions LLC
    Inventor: Thomas E. Wagner
  • Patent number: 11826476
    Abstract: The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making prophylactic and therapeutic vaccines.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: November 28, 2023
    Assignee: ORBIS HEALTH SOLUTIONS, LLC
    Inventors: Thomas E. Wagner, George E. Peoples, Jr.
  • Publication number: 20230346904
    Abstract: The present invention generally relates to compositions and methods for delivering a vaccine.
    Type: Application
    Filed: November 16, 2022
    Publication date: November 2, 2023
    Applicant: ORBIS HEALTH SOLUTIONS LLC
    Inventor: Thomas E. Wagner
  • Patent number: 11759429
    Abstract: The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making prophylactic and therapeutic vaccines.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: September 19, 2023
    Assignee: Orbis Health Solutions, LLC
    Inventor: Thomas E. Wagner
  • Patent number: 11529414
    Abstract: The present disclosure provides particles for delivering a nucleic acid that encodes an immunogenic peptide in an antigen presenting cell. The disclosed particles can function as a vaccine and can be used to treat or prevent a viral or bacterial infection in a subject by expressing in vivo an immunogenic peptide, thereby stimulating the subject's immune system to attack the virus or bacteria that naturally express the immunogenic peptide.
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: December 20, 2022
    Assignee: ORBIS HEALTH SOLUTIONS, LLC
    Inventor: Thomas E. Wagner
  • Publication number: 20220162644
    Abstract: The present disclosure provides delivery vectors for expressing a chimeric receptor in a monocytic cell, such as a macrophage or dendritic cell. The chimeric receptor may specifically bind to a particular antigen or target molecule, such as an immune checkpoint protein or OX40. The disclosed delivery vectors can be used to treat cancer in a subject by expressing in vivo a chimeric receptor on the surface of the subject's monocytic cells.
    Type: Application
    Filed: May 28, 2020
    Publication date: May 26, 2022
    Applicant: ORBIS HEALTH SOLUTIONS, LLC
    Inventor: Thomas E. Wagner
  • Publication number: 20220151943
    Abstract: The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making prophylactic and therapeutic vaccines.
    Type: Application
    Filed: November 22, 2021
    Publication date: May 19, 2022
    Applicant: ORBIS HEALTH SOLUTIONS, LLC
    Inventor: Thomas E. Wagner
  • Publication number: 20210393771
    Abstract: The present disclosure provides particles for delivering a nucleic acid that encodes an immunogenic peptide in an antigen presenting cell. The disclosed particles can function as a vaccine and can be used to treat or prevent a viral or bacterial infection in a subject by expressing in vivo an immunogenic peptide, thereby stimulating the subject's immune system to attack the virus or bacteria that naturally express the immunogenic peptide.
    Type: Application
    Filed: June 23, 2020
    Publication date: December 23, 2021
    Applicant: ORBIS HEALTH SOLUTIONS, LLC
    Inventor: Thomas E. Wagner
  • Patent number: 11179343
    Abstract: The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making prophylactic and therapeutic vaccines.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: November 23, 2021
    Assignee: Orbis Health Solutions, LLC
    Inventor: Thomas E. Wagner
  • Publication number: 20210252052
    Abstract: Dendritic cells containing tumor lysate loaded particles are prepared. The dendritic cells present tumor antigens to elicit the Major Histocompatibility Complex class I pathway and can be used as a vaccine to treat cancer, including ocular melanoma.
    Type: Application
    Filed: December 21, 2020
    Publication date: August 19, 2021
    Applicant: Orbis Health Solutions LLC
    Inventor: Thomas E. WAGNER
  • Patent number: 10869885
    Abstract: Dendritic cells containing tumor lysate loaded particles are prepared. The dendritic cells present tumor antigens to elicit the Major Histocompatibility Complex class I pathway and can be used as a vaccine to treat cancer, including ocular melanoma.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: December 22, 2020
    Assignee: Orbis Health Solutions LLC
    Inventor: Thomas E. Wagner
  • Publication number: 20200368172
    Abstract: The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making prophylactic and therapeutic vaccines.
    Type: Application
    Filed: June 5, 2020
    Publication date: November 26, 2020
    Applicant: ORBIS HEALTH SOLUTIONS, LLC
    Inventor: Thomas E. Wagner
  • Patent number: 10801041
    Abstract: The present invention relates generally to a gene expression system utilizing an alphavirus replicon and T7 promoter. The system is capable of expressing proteins in the cell cytoplasm without integrating the gene of interest into the genome of a host cell. The invention has a wide range of applications such as producing induced pluripotent cells and vaccines against pathogens and cancers.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: October 13, 2020
    Assignee: Orbis Health Solutions, LLC
    Inventor: Thomas E. Wagner
  • Patent number: 10675249
    Abstract: The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making prophylactic and therapeutic vaccines.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: June 9, 2020
    Assignee: Orbis Health Solutions, LLC
    Inventor: Thomas E. Wagner
  • Publication number: 20200139895
    Abstract: A trailer hitch mounted recycling, transporting, and even a waste container transporting apparatus includes a tubing connector, that secures with the trailer hitch of a vehicle, and having a support plate, that mounts a lifting tube permanently thereon. A pivot rod pivotally secures to the upper end of the lifting tube, and the pivot rod connects with a lifting lever, which when pivoted from a vertical to a horizontal position, allows for movement of a container either onto or off of the ground, in preparation for its transport, or removal from this apparatus. A lifting hook slidably engages with the lifting tube, and connects with a lifting bracket at its upper end, which connects with a short lever, that provides a sliding movement to the lifting hook either upwardly with respect to the lifting tube, or downwardly therefrom, so that its hook device can secure to the container to provide for its lifting, transport, and lowering, after it has been moved to a distant location.
    Type: Application
    Filed: November 1, 2019
    Publication date: May 7, 2020
    Inventor: Thomas E. Wagner
  • Publication number: 20200069596
    Abstract: The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making prophylactic and therapeutic vaccines.
    Type: Application
    Filed: November 6, 2019
    Publication date: March 5, 2020
    Applicant: ORBIS HEALTH SOLUTIONS, LLC
    Inventor: Thomas E. Wagner